Arcturus Therapeutics Reports Third-Quarter 2026 Financial Results
Arcturus Therapeutics announced results for the quarter ended September 30, 2026, and provided corporate updates.
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, NASDAQ:ARCT), a messenger RNA medicines company focused on the development of liver and respiratory therapeutics, today announced its financial results for the quarter ended September 30, 2026, and provided corporate updates.“The third…